Lentiboost formulated, GMP-grade

Ended Purchase Order Awarded Last action

Contract number
75N90024P00094
Awardee
Awarding agency
Obligated
$10,970

Award facts

Contract value 100% obligated
$10,970.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,970 purchase order to Sirion Biotech GMBH for LENTIBOOST formulated, GMP-grade products. Sirion Biotech GMBH, a division of Revvity Inc. Medical Imaging, LLC, will deliver the requested products from its facilities in Germany by December 29, 2023. The award was made utilizing firm-fixed pricing. No subcontractors or set-aside designations were indicated. The National Institutes of Health Clinical Center supports the NIH's intramural research program and regularly procures specialized medical products and technologies to advance treatment of complex medical conditions.

Quick answers

Who was awarded contract 75N90024P00094?

75N90024P00094 was awarded to Revvity Gene Delivery GMBH by NIH Clinical Center (National Institutes of Health) on December 7, 2023.

How much is contract 75N90024P00094 worth?

The government has obligated $10,970 on 75N90024P00094.

Was contract 75N90024P00094 competed?

The extent of competition for 75N90024P00094 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login